Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces the launch of the Prolaris + AI Test at the end of this month. Prolaris will be the ...

Prostate-specific antigen (PSA) blood testing likely reduces the risk of death from prostate cancer, found a new review ...

A landmark review of nearly 800,000 men has found that PSA blood tests do reduce prostate cancer deaths — a shift from ...

For Josh Henderson, 66, of Olympia, getting genetic testing was a no-brainer. “The first time I came to Fred Hutch, my oncologist suggested it,” said the retired IT manager who received a metastatic ...

Noninvasive monitoring of low-grade prostate cancer with a urinary biomarker test could reduce the need for biopsies and serial imaging, according to a study ...

Tempus AI is expanding its clinical oncology offering with the launch of ArteraAI Prostate Test for metastatic hormone-sensitive prostate cancer. ・The tool combines digital pathology and genomic ...

Health-evidence reviewers reverse recommendation on a blood test that detects a biomarker of a common cancer after decades of ...

ORLANDO, Fla. — September marks Prostate Cancer Awareness Month, which experts at the Cleveland Clinic say serves as a reminder for men to prioritize their health. Doctors emphasize the importance of ...

An informational website and a mobile testing van in Philadelphia are making it easier to learn about cancer and get tested. Hall of Fame running back Emmitt Smith will be hosting a series of short ...